title: Anti-Müllerian hormone and polycystic ovary syndrome.
abstract: Anti-Müllerian hormone (AMH) is a glycoprotein, a member of the transforming growth factor β family, reflecting the number of ovarian antral follicles. Polycystic ovary syndrome (PCOS) is a common endocrinopathy predisposing to infertility, and metabolic and cardiovascular complications. In our review, we discuss the role of AMH in PCOS pathophysiology and its clinical applications according to the published studies. Improvement of AMH assay validity will allow the clinical utility of this valuable biomarker to be widened. (Endokrynol Pol 2017; 68 (1): 74-78).
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Łebkowska
authors.affiliation: Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Poland. irinak@poczta.onet.pl.
authors.forename: Irina
authors.initials: I
authors.lastname: Kowalska
mesh_terms: D054304:Anti-Mullerian Hormone; D005260:Female; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000378:metabolism* / Q000503:physiopathology
chemical_list: D054304:Anti-Mullerian Hormone
keywords: AMH; PCOS; assisted reproductive technology; insulin resistance; polycystic ovarian morphology